Technology | 2010.01.13
Pathway Medical Technologies Receives FDA 510(k) Clearance for JETSTREAM G3™ Atherectomy System
KIRKLAND, Wash.--(BUSINESS WIRE)--Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced that the U.S. Food & Drug Administration (FDA) has granted the company 510(k) clearance to market JETSTREAM G3™, its newest peripheral revascularization catheter for the treatment of PVD. With a new distal cutter and enhanced aspiration efficiency, JETSTREAM G3 offers a significant improvement in cutting and removing diseas
For more information, please visit
http://www.businesswire.com/news/home/20100113005438/en
